EATON VANCE MANAGEMENT - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$19,126,000
-18.4%
102,218
-29.2%
0.03%
-15.2%
Q2 2022$23,434,000
-14.0%
144,300
-0.4%
0.03%
+6.5%
Q1 2022$27,239,000
-22.6%
144,824
+9.0%
0.03%
-27.9%
Q4 2021$35,178,000
-7.6%
132,832
+0.1%
0.04%
-18.9%
Q3 2021$38,067,000
+43.2%
132,695
-0.4%
0.05%
+47.2%
Q2 2021$26,588,000
+3.5%
133,193
+0.8%
0.04%
-5.3%
Q1 2021$25,683,000
-49.2%
132,105
-49.9%
0.04%
-5.0%
Q4 2020$50,528,000
+159.9%
263,674
+100.1%
0.04%
+11.1%
Q3 2020$19,443,000
+19.4%
131,7840.0%0.04%
+9.1%
Q2 2020$16,290,000
+28.1%
131,784
+0.0%
0.03%
+6.5%
Q1 2020$12,719,000
+4.4%
131,7440.0%0.03%
+29.2%
Q4 2019$12,186,000
+20.6%
131,7440.0%0.02%
+9.1%
Q3 2019$10,103,000
-10.7%
131,744
+0.1%
0.02%
-12.0%
Q2 2019$11,315,000
+45.5%
131,6500.0%0.02%
+38.9%
Q1 2019$7,778,000
+12.0%
131,650
-0.0%
0.02%0.0%
Q4 2018$6,946,000
-4.9%
131,707
+0.0%
0.02%
+12.5%
Q3 2018$7,301,000
+17.9%
131,6500.0%0.02%
+6.7%
Q2 2018$6,193,000
+570.2%
131,650
+415.1%
0.02%
+1400.0%
Q1 2018$924,000
+99.1%
25,560
+100.0%
0.00%0.0%
Q4 2017$464,000
-5.1%
12,780
+0.1%
0.00%0.0%
Q3 2017$489,000
-7.6%
12,768
+0.1%
0.00%0.0%
Q2 2017$529,00012,7540.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders